Latest filing published 07 Jun 2023 for Pacira BioSciences, Inc., €81k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Anthony Molloy: trading record in brief
Anthony Molloy is a declared insider of Pacira BioSciences, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 17 filings; the first trade dates from 4 January 2022 and the latest from 6 June 2023.
Sales make up the whole of the open-market record (11 sales, €2.2M). The rest of the record consists of 2 share grants and 4 option exercises. So far in 2023, the count stands at no purchases and 4 sales.
The latest filing, published on 7 June 2023, reports an open-market sale of €163k in Pacira BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anthony Molloy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,267 shares@ US$38.27720.6% of flowCommon StockSEC:0001209191-23-035259:0
- 158 shares@ US$39.0931.5% of flowCommon StockSEC:0001209191-23-002474:0
- 2,980 shares@ US$61.37444.8% of flowCommon StockSEC:0001209191-22-035226:0
- 3,000 shares@ US$40.3429.1% of flowCommon StockSEC:0001209191-22-023856:0
- 224 shares@ US$63.553.3% of flowCommon StockSEC:0001209191-22-004198:0
- 2,000 shares0Common StockSEC:0001209191-22-002725:0
6 of 6 declarations
